• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物制剂在治疗甲银屑病中的作用。

The role of biological agents in the treatment of nail psoriasis.

机构信息

Greater Miami Skin and Laser Center, Department of Dermatology, Mount Sinai Medical Center, Miami Beach, FL 33140, USA.

出版信息

Am J Clin Dermatol. 2010;11 Suppl 1:27-30. doi: 10.2165/1153418-S0-000000000-00000.

DOI:10.2165/1153418-S0-000000000-00000
PMID:20586503
Abstract

Nail psoriasis affects up to 90% of patients with psoriasis in their lifetime and is seen in 80% of patients with psoriatic arthritis. These changes of nail psoriasis often cause significant pain, psychological effects, and result in restrictions of daily activities. In patients with nail psoriasis, the choice of effective therapy is limited and depends on various factors, including the severity of the disease, the ability of patients to tolerate treatment, and their ability to pay (insurance) for what are, in some cases, expensive treatments. In recent years, biological therapies have proved effective in improving nail psoriasis, have generally proved to be well tolerated and require minimal patient monitoring. In the right situation, therefore, the use of biological agents is justified in patients with psoriatic nail disease.

摘要

指甲银屑病影响高达 90%的银屑病患者一生中,并在 80%的银屑病关节炎患者中可见。这些指甲银屑病的变化常常导致显著的疼痛、心理影响,并导致日常活动受限。在指甲银屑病患者中,有效的治疗选择是有限的,取决于多种因素,包括疾病的严重程度、患者对治疗的耐受能力以及他们对(某些情况下昂贵)治疗的支付能力(保险)。近年来,生物疗法已被证明可有效改善指甲银屑病,通常被证明具有良好的耐受性,并且需要对患者进行最少的监测。因此,在适当的情况下,生物制剂在银屑病指甲疾病患者中是合理的。

相似文献

1
The role of biological agents in the treatment of nail psoriasis.生物制剂在治疗甲银屑病中的作用。
Am J Clin Dermatol. 2010;11 Suppl 1:27-30. doi: 10.2165/1153418-S0-000000000-00000.
2
Approach to managing patients with nail psoriasis.指甲银屑病患者的管理方法。
J Eur Acad Dermatol Venereol. 2009 Sep;23 Suppl 1:15-21. doi: 10.1111/j.1468-3083.2009.03364.x.
3
Marked improvement in nail psoriasis during treatment with etanercept.治疗用依那西普治疗时,指甲银屑病有明显改善。
Dermatol Ther. 2011 Sep-Oct;24(5):498-500. doi: 10.1111/j.1529-8019.2012.01472.x.
4
Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.从其他治疗转换至依那西普治疗银屑病的疗效与安全性:一项观察性研究
Am J Clin Dermatol. 2009;10(5):319-24. doi: 10.2165/11310770-000000000-00000.
5
Extended report: nail disease in psoriatic arthritis--clinically important, potentially treatable and often overlooked.扩展报告:银屑病关节炎中的指甲疾病——具有临床重要性、潜在可治疗性且常被忽视。
Rheumatology (Oxford). 2004 Jun;43(6):790-4. doi: 10.1093/rheumatology/keh198. Epub 2004 Apr 27.
6
Management of psoriatic nail disease.银屑病甲病的管理
Semin Cutan Med Surg. 2009 Mar;28(1):39-43. doi: 10.1016/j.sder.2008.12.003.
7
Managing pediatric patients with psoriasis.儿童银屑病患者的管理。
Am J Clin Dermatol. 2010;11 Suppl 1:15-7. doi: 10.2165/1153415-S0-000000000-00000.
8
Treatment of nail psoriasis with adalimumab: an open label unblinded study.阿达木单抗治疗甲银屑病:一项开放性、非盲研究。
J Eur Acad Dermatol Venereol. 2010 May;24(5):530-4. doi: 10.1111/j.1468-3083.2009.03453.x. Epub 2009 Oct 6.
9
Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study.英夫利昔单抗治疗银屑病甲的疗效和安全性评估:一项非盲、非随机、开放标签研究。
Br J Dermatol. 2008 Aug;159(2):453-6. doi: 10.1111/j.1365-2133.2008.08686.x. Epub 2008 Jun 28.
10
The burden of nail psoriasis: an introduction.指甲银屑病的负担:引言。
Dermatology. 2010;221 Suppl 1:1-5. doi: 10.1159/000316169. Epub 2010 Aug 9.

引用本文的文献

1
Treatment of nail psoriasis: common concepts and new trends.甲银屑病的治疗:常见概念与新趋势
Dermatol Res Pract. 2013;2013:180496. doi: 10.1155/2013/180496. Epub 2013 May 13.